Abbott's FreeStyle Libre 3 Plus Now Covered Across Canada

Abbott's (NYSE: ABT) newest sensor-based glucose technology, the FreeStyle Libre 3 Plus* sensor, is now publicly funded in ...
Nasdaq

Tandem Diabetes Care’s t:slim X2™ Insulin Pump is the First Automated Insulin Delivery System to Integrate with Abbott’s New FreeStyle Libre® 2 Plus Sensor

Abbott’s latest innovation, the FreeStyle Libre® 2 Plus sensor, is available for the first time for t:slim X2™ insulin pump users in the U.S. Tandem’s Control-IQ™ hybrid closed-loop technology now ...
Drug Store News

Tandem Diabetes Care’s latest insulin pump integrates with Abbott’s FreeStyle Libre 2 Plus Sensor

Tandem’s Control-IQTM hybrid closed-loop technology now integrates with the 15-day continuous glucose monitoring sensor. This ad will auto-close in 10 seconds ...
Morningstar

t:slim X2™ Insulin Pump Now Available with Abbott’s FreeStyle Libre® 3 Plus Sensor in the United States

Tandem Diabetes Care begins global commercial rollout of t:slim X2 pump integration with the FreeStyle Libre 3 Plus CGM sensor, expanding choice and personalization for people living with diabetes ...
Seeking Alpha

Insulet gets CE Mark for Omnipod 5 with FreeStyle Libre 2 sensor

Insulet (NASDAQ:PODD) said it has received European approval for its Omnipod 5 automated insulin delivery system integrated with Abbott’s (ABT) FreeStyle Libre 2 Plus sensor. The product received a CE ...